Cargando…
Serum Vascular Endothelial Growth Factor Level in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation: Experience of a Single Western Center
Background: The strongest predictor of tumor relapse after liver transplantation for hepatocellular carcinoma (HCC) is vascular invasion, appreciated only on explant analysis. High serum level of vascular endothelial growth factor (VEGF) is associated with worse outcomes after resection or locoregio...
Autores principales: | Tan, A., Kim, R., El-Gazzaz, G., Menon, N., Aucejo, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Avicenna Organ Transplantation Institute
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089276/ https://www.ncbi.nlm.nih.gov/pubmed/25013622 |
Ejemplares similares
-
Liver Transplantation for Hepatocellular Carcinoma among African Americans in the United States
por: Sourianarayanane, A., et al.
Publicado: (2012) -
Impact of Hypothyroidism on Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation
por: Salman, Ahmed, et al.
Publicado: (2021) -
Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease
por: Papageorgiou, Maria-Vasiliki, et al.
Publicado: (2017) -
Peribiliary gland damage due to liver transplantation involves peribiliary vascular plexus and vascular endothelial growth factor
por: Franchitto, Antonio, et al.
Publicado: (2019) -
Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience
por: Ju, Michelle R., et al.
Publicado: (2020)